You are currently viewing a new version of our website. To view the old version click .
MDPIMDPI
Search all articles
Vaccines
Submit to Vaccines

Vaccines, Volume 10, Issue 6

June 2022 - 152 articles

Cover Story: Patients from socially deprived and ethnic minority backgrounds associated with increased COVID-19 vaccine hesitancy are over-represented in the renal replacement therapy (RRT) population. A bespoke vaccination programme was designed with the involvement of a multidisciplinary team, using clinical teams as trusted messengers, patient engagement, local safety, and efficacy data to ensure equitable access to this life-saving intervention. The results of the programme showed that the total uptake for a first dose of COVID-19 vaccination was high at 96.7% and there were no statistically significant differences in patients from ethnic minority groups or socially deprived backgrounds. The vaccination uptake was higher compared to the reference regional adult clinically extremely vulnerable population. This work can inform other initiatives to address health inequalities in RRT patients. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (152)

  • Article
  • Open Access
12 Citations
3,276 Views
20 Pages
Download PDF

Impact of DNA Prime/Protein Boost Vaccination against Campylobacter jejuni on Immune Responses and Gut Microbiota in Chickens

  • Noémie Gloanec,
  • Daniel Dory,
  • Ségolène Quesne,
  • Véronique Béven,
  • Typhaine Poezevara,
  • Alassane Keita,
  • Marianne Chemaly and
  • Muriel Guyard-Nicodème
Vaccines2022, 10(6), 981;https://doi.org/10.3390/vaccines10060981

20 June 2022

Campylobacteriosis is reported to be the leading zoonosis in Europe, and poultry is the main reservoir of Campylobacter. Despite all the efforts made, there is still no efficient vaccine to fight this bacterium directly in poultry. Recent studies hav...

Full Article
  • Article
  • Open Access
12 Citations
4,442 Views
14 Pages
Download PDF

Broad Cross-Reactive IgA and IgG against Human Coronaviruses in Milk Induced by COVID-19 Vaccination and Infection

  • Jiong Wang,
  • Bridget E. Young,
  • Dongmei Li,
  • Antti Seppo,
  • Qian Zhou,
  • Alexander Wiltse,
  • Anna Nowak-Wegrzyn,
  • Katherine Murphy,
  • Kaili Widrick and
  • Nicole Diaz
  • + 3 authors
Vaccines2022, 10(6), 980;https://doi.org/10.3390/vaccines10060980

20 June 2022

It is currently unclear if SARS-CoV-2 infection or mRNA vaccination can also induce IgG and IgA against common human coronaviruses (HCoVs) in lactating parents. Here we prospectively analyzed human milk (HM) and blood samples from lactating parents t...

Full Article
  • Article
  • Open Access
15 Citations
3,648 Views
11 Pages
Download PDF

Immunization with Pooled Antigens for Clostridium perfringens Conferred Partial Protection against Experimental Necrotic Enteritis in Broiler Chickens

  • Baohong Yuan,
  • Zhifeng Sun,
  • Mingmin Lu,
  • Hyun Lillehoj,
  • Youngsub Lee,
  • Liheng Liu,
  • Xianghe Yan,
  • Danchen Aaron Yang and
  • Charles Li
Vaccines2022, 10(6), 979;https://doi.org/10.3390/vaccines10060979

20 June 2022

Necrotic enteritis (NE) is a multifactorial and important enteric infectious disease etiologically caused by pathogenic C. perfringens infection, accounting for the estimated loss of around USD 6 billion in the global poultry industry. The increasing...

Full Article
  • Article
  • Open Access
3,567 Views
15 Pages
Download PDF

Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study

  • Lama T AlMutairi,
  • Wesal Y Alalayet,
  • Sondus I Ata,
  • Khalidah A Alenzi and
  • Yazed AlRuthia
Vaccines2022, 10(6), 977;https://doi.org/10.3390/vaccines10060977

20 June 2022

Objective: The aim of this study was to explore the side effects of COVID-19 vaccines among a mixed gender sample of patients on monoclonal antibody biologics (mAbs) in Saudi Arabia. Methods: This was a prospective questionnaire-based cross-sectional...

Full Article
  • Article
  • Open Access
3 Citations
2,297 Views
10 Pages
Download PDF

Predictors of Mortality in Tocilizumab-Treated Severe COVID-19

  • Konstantinos Pagkratis,
  • Serafeim Chrysikos,
  • Emmanouil Antonakis,
  • Aggeliki Pandi,
  • Chrysavgi Nikolaou Kosti,
  • Eleftherios Markatis,
  • Georgios Hillas,
  • Antonia Digalaki,
  • Sofia Koukidou and
  • Eleftheria Chaini
  • + 3 authors
Vaccines2022, 10(6), 978;https://doi.org/10.3390/vaccines10060978

20 June 2022

Purpose: Tocilizumab is associated with positive outcomes in severe COVID-19. We wanted to describe the characteristics of nonresponders to treatment. Methods: This was a retrospective multicenter study in two respiratory departments investigating ad...

Full Article
  • Article
  • Open Access
6 Citations
3,589 Views
15 Pages
Download PDF

A Needs-Based Analysis of Teaching on Vaccinations and COVID-19 in German Medical Schools

  • Franziska Baessler,
  • Ali Zafar,
  • Katharina Mengler,
  • Ricarda Nadine Natus,
  • Anne Josephine Dutt,
  • Manuel Kuhlmann,
  • Emre Çinkaya and
  • Simon Hennes
Vaccines2022, 10(6), 975;https://doi.org/10.3390/vaccines10060975

19 June 2022

The COVID-19 pandemic highlights the need for improving public confidence in vaccines. Academic gaps and redundancies on vaccinations must be identified to revise the medical curriculum for up-to-date training of medical students. This cross-sectiona...

Full Article
  • Brief Report
  • Open Access
17 Citations
2,936 Views
9 Pages
Download PDF

Flu and COVID-19 Vaccination: What Happens to the Flu Shot When the Campaigns Overlap? Experience from a Large Italian Research Hospital

  • Domenico Pascucci,
  • Mario Cesare Nurchis,
  • Alberto Lontano,
  • Eleonora Marziali,
  • Giuseppe Vetrugno,
  • Andrea Cambieri,
  • Umberto Moscato,
  • Andrea Di Pilla,
  • Gianfranco Damiani and
  • Patrizia Laurenti
Vaccines2022, 10(6), 976;https://doi.org/10.3390/vaccines10060976

19 June 2022

Influenza represents a threat to global health and health care workers (HCWs) have an increased risk of contracting the influenza virus in the workplace. The COVID-19 pandemic has brought back the importance of influenza vaccination, as the influenza...

Full Article
  • Review
  • Open Access
18 Citations
9,869 Views
12 Pages
Download PDF

Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13

  • Corrado Pelaia,
  • Giulia Pelaia,
  • Claudia Crimi,
  • Angelantonio Maglio,
  • Giuseppe Armentaro,
  • Cecilia Calabrese,
  • Angela Sciacqua,
  • Luca Gallelli and
  • Alessandro Vatrella
Vaccines2022, 10(6), 974;https://doi.org/10.3390/vaccines10060974

19 June 2022

Interleukin-4 (IL-4) and interleukin-13 (IL-13) are key cytokines involved in the pathophysiology of both immune-inflammatory and structural changes underlying type 2 asthma. IL-4 plays a pivotal role in Th2 cell polarization, immunoglobulin E (IgE)...

Full Article
  • Article
  • Open Access
185 Citations
23,209 Views
13 Pages
Download PDF

The Health Belief Model Applied to COVID-19 Vaccine Hesitancy: A Systematic Review

  • Yam B. Limbu,
  • Rajesh K. Gautam and
  • Long Pham
Vaccines2022, 10(6), 973;https://doi.org/10.3390/vaccines10060973

18 June 2022

This study systematically analyzes the research that used the Health Belief Model (HBM) as a theoretical basis to examine the influence of HBM constructs on COVID-19 vaccine hesitancy. Following PRISMA guidelines, PubMed, Web of Science, Google Schol...

Full Article
  • Article
  • Open Access
8 Citations
2,865 Views
14 Pages
Download PDF

Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients

  • Laura Thümmler,
  • Michael Koldehoff,
  • Neslinur Fisenkci,
  • Leonie Brochhagen,
  • Peter A. Horn,
  • Adalbert Krawczyk and
  • Monika Lindemann
Vaccines2022, 10(6), 972;https://doi.org/10.3390/vaccines10060972

18 June 2022

Protecting vulnerable groups from severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection is mandatory. Immune responses after a third vaccination against SARS-CoV-2 are insufficiently studied in patients after hematopoietic stem-...

Full Article

of 16

Go to next page

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X
Imprint
Download Flyer